Kristina Allikmets, M.D., Ph.D., is a Senior Vice President at Takeda Pharmaceuticals, heading the R&D organization in the Plasma-Derived Therapies Business Unit. Previously, Dr. Allikmets has held various leadership roles in Takeda, serving most recently as a “chief executive” of a “spin-in” company within Takeda Global R&D, to take one of Takeda’s compounds through experimental phase of development following a new working model. Prior, she was responsible for establishing the R&D Access to Medicines activities and starting up the R&D Patient Engagement team. Her roles before include the leadership of Clinical Science team in CNS Therapy Area Unit and heading Clinical Development in Immunology and Respiratory Therapy Area Unit. Before joining Takeda, Dr. Allikmets served as the Chief Medical Officer for Nycomed Pharma.
Dr. Allikmets is a member of the Advisory Board of Boston University Bioengineering Technology & Entrepreneurship Center (BTEC) and serves on the Board of Directors of Cures Within Reach, a non-profit organization that focuses on drug repurposing research.
Dr. Allikmets holds an M.D. and a Ph.D. in cardiovascular research from University of Tartu, Estonia. She’s certified in cardiology and internal medicine and practiced for almost 15 years before joining the pharmaceutical industry. She spent most of her career in several European countries. Having moved to the states in 2015, she is currently based in Boston, MA.